23 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Viveve Medical, Inc. VIVE shares surged 22.4% to $5.40 during Tuesday's pre-market session. The market value of their outstanding shares is at $3.3 million. According to the most recent rating by Ladenburg Thalmann, on July 24, the current rating is at Neutral.
• Geron, Inc. GERN shares rose 12.0% to $1.49. The market cap stands at $254.3 million. The most recent rating by H.C. Wainwright, on September 03, is at Buy, with a price target of $4.00.
• Titan Pharmaceuticals, Inc. TTNP stock increased by 11.5% to $0.30. The market value of their outstanding shares is at $5.2 million.
• CHF Solutions, Inc. CHFS stock increased by 10.0% to $1.65. The market cap stands at $5.8 million.
• Catabasis Pharmaceuticals, Inc. CATB shares rose 5.6% to $5.70. The market value of their outstanding shares is at $60.2 million.
• Advaxis, Inc. ADXS shares rose 5.5% to $0.28. The market value of their outstanding shares is at $6.1 million.
• Mallinckrodt, Inc. MNK shares surged 5.4% to $2.54. The market cap seems to be at $212.5 million. The most recent rating by Stifel, on September 09, is at Hold, with a price target of $8.00.
• Jaguar Health, Inc. JAGX shares increased by 5.3% to $1.38. The market cap seems to be at $9.0 million. The most recent rating by Ladenburg Thalmann, on September 12, is at Buy, with a price target of $5.00.
• Brookdale Senior Living, Inc. BKD shares rose 4.2% to $7.90. The market cap seems to be at $1.3 billion. The most recent rating by Barclays, on September 03, is at Equal-Weight, with a price target of $8.00.
• VBI Vaccines, Inc. VBIV shares rose 3.6% to $0.49. The market cap seems to be at $51.5 million.
• Aphria, Inc. APHA shares moved upwards by 2.0% to $5.30. The market cap stands at $1.4 billion. According to the most recent rating by CIBC, on July 26, the current rating is at Underperformer.
• Teva Pharmaceutical Indus, Inc. TEVA stock increased by 1.9% to $7.01. The market cap stands at $7.6 billion. The most recent rating by Wells Fargo, on September 30, is at Market Perform, with a price target of $8.00.
• Endo International, Inc. ENDP shares moved upwards by 1.9% to $3.27. The market value of their outstanding shares is at $715.3 million. The most recent rating by Morgan Stanley, on July 15, is at Underweight, with a price target of $3.00.

Losers

• Minerva Neurosciences, Inc. NERV stock declined 28.6% to $5.53 during Tuesday's pre-market session. The market value of their outstanding shares is at $320.3 million. The most recent rating by Chardan Capital, on September 25, is at Buy, with a price target of $17.00.
• Genfit, Inc. GNFT shares fell 10.3% to $15.61. The market cap seems to be at $661.5 million.
• Sienna Biopharmaceuticals, Inc. SNNA shares plummeted 10.2% to $0.18. The market cap seems to be at $3.4 million. The most recent rating by BMO Capital, on September 05, is at Outperform, with a price target of $3.00.
• Guardion Health Sciences, Inc. GHSI shares declined 3.2% to $0.74. The market cap seems to be at $28.3 million.
• Zealand Pharma, Inc. ZEAL stock fell 2.2% to $24.80. The market cap seems to be at $970.3 million. According to the most recent rating by Guggenheim, on September 20, the current rating is at Buy.
• Galapagos, Inc. GLPG stock decreased by 2.1% to $149.41. The market value of their outstanding shares is at $9.7 billion. The most recent rating by Morgan Stanley, on September 10, is at Overweight, with a price target of $200.00.
• Neurotrope, Inc. NTRP shares decreased by 2.1% to $0.79. The market cap seems to be at $10.2 million. According to the most recent rating by Janney Capital, on September 11, the current rating is at Neutral.
• Qiagen, Inc. QGEN stock fell 1.6% to $32.47. The market cap stands at $7.4 billion. According to the most recent rating by Evercore ISI Group, on July 16, the current rating is at In-Line.
• HEXO, Inc. HEXO stock declined 1.4% to $3.91. The market cap stands at $1.0 billion.
• Fresenius Medical Care, Inc. FMS stock plummeted 1.2% to $33.22. The market value of their outstanding shares is at $20.8 billion. According to the most recent rating by BTIG, on August 01, the current rating is at Neutral.